DOJ throws support to Oscar in Florida Blue legal fight

An Oscar Health lawsuit alleging Florida Blue's broker policy is anticompetitive shouldn't be dismissed based on the McCarran-Ferguson Act, according to the Department of Justice.

In a statement of interest obtained by the Daily Business Review, the Justice Department said the McCarran-Ferguson Act, which exempts insurance business from most federal regulation, should not be used as a basis to dismiss the case.

Oscar Health sued Florida Blue in November 2018 over its exclusive broker policy, which Oscar argues excludes insurance brokers who work with Florida Blue from selling policies of other insurers. Oscar claimed that Florida Blue's policy — coupled with its market dominance — allows the insurer to effectively operate as a monopoly.

More articles on payers:
Judge steps down from UnitedHealth case over 'immoral' denial of cancer treatment
House Democrats unveil Medicare expansion plan: 8 things to know
Humana posts $566M profit in Q1

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months